Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-13-002624
Filing Date
2013-07-26
Accepted
2013-07-26 16:30:15
Documents
5
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT admp-10ka_033113.htm 10-K/A 413216
2 CERTIFICATION PURSUANT TO SECTION 302 ex-31_1.htm EX-31.1 18273
3 CERTIFICATION PURSUANT TO SECTION 302 ex-31_2.htm EX-31.2 18173
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 7680
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_2.htm EX-32.2 8043
  Complete submission text file 0001387131-13-002624.txt   466521
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 000-26372 | Film No.: 13989857
SIC: 2834 Pharmaceutical Preparations